Company intelligence / Profile preview

Anke Bio

Hefei, Anhui, Chinaankebio.com ↗
Ownership
Private
Employees
~2800
Development stage
Other
01

Overview

Anke Bio is a prominent Chinese biopharmaceutical company focused on the development and commercialization of recombinant DNA products and diagnostic reagents. The company is widely recognized for its market-leading endocrinology portfolio, specifically its recombinant human growth hormone product, Ansomone. In addition to growth hormones, Anke Bio produces interferon-based therapies for infectious diseases and is actively expanding into the oncology sector with biosimilars and innovative cell therapies. Through its subsidiary PersonGen, the company is advancing a pipeline of CAR-T cell therapies targeting various hematological and solid tumors. Headquartered in Hefei, Anke Bio maintains integrated R&D and large-scale GMP manufacturing capabilities to support its domestic and international growth.

Therapeutic areas
OncologyEndocrinologyInfectious Diseases
Modalities
HormoneCytokineMonoclonal antibodyCAR-T cell therapyRecombinant protein
Industry
Biotech
02

Drug pipeline

10 assets

AK1012

3

9 more assets in the full pipeline.

03

Partnerships

PersonGen Biotherapeutics

Beyond the preview

Go deeper on Anke Bio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Anke Bio.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call